1 Market Overview
1.1 Brigatinib Tablet Introduction
1.2 Market Analysis by Type
1.2.1 Overview: Global Brigatinib Tablet Revenue by Type: 2017 Versus 2021 Versus 2028
1.2.2 30mg
1.2.3 50mg
1.2.4 180mg
1.3 Market Analysis by Application
1.3.1 Overview: Global Brigatinib Tablet Revenue by Application: 2017 Versus 2021 Versus 2028
1.3.2 Hospital
1.3.3 Pharmacy
1.4 Global Brigatinib Tablet Market Size & Forecast
1.4.1 Global Brigatinib Tablet Sales in Value (2017 & 2021 & 2028)
1.4.2 Global Brigatinib Tablet Sales in Volume (2017-2028)
1.4.3 Global Brigatinib Tablet Price (2017-2028)
1.5 Global Brigatinib Tablet Production Capacity Analysis
1.5.1 Global Brigatinib Tablet Total Production Capacity (2017-2028)
1.5.2 Global Brigatinib Tablet Production Capacity by Geographic Region
1.6 Market Drivers, Restraints and Trends
1.6.1 Brigatinib Tablet Market Drivers
1.6.2 Brigatinib Tablet Market Restraints
1.6.3 Brigatinib Tablet Trends Analysis
2 Manufacturers Profiles
2.1 ARIAD Pharmaceuticals
2.1.1 ARIAD Pharmaceuticals Details
2.1.2 ARIAD Pharmaceuticals Major Business
2.1.3 ARIAD Pharmaceuticals Brigatinib Tablet Product and Services
2.1.4 ARIAD Pharmaceuticals Brigatinib Tablet Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
3 Brigatinib Tablet Breakdown Data by Manufacturer
3.1 Global Brigatinib Tablet Sales in Volume by Manufacturer (2019, 2020, 2021, and 2022)
3.2 Global Brigatinib Tablet Revenue by Manufacturer (2019, 2020, 2021, and 2022)
3.3 Key Manufacturer Market Position in Brigatinib Tablet
3.4 Market Concentration Rate
3.4.1 Top 3 Brigatinib Tablet Manufacturer Market Share in 2021
3.4.2 Top 6 Brigatinib Tablet Manufacturer Market Share in 2021
3.5 Global Brigatinib Tablet Production Capacity by Company: 2021 VS 2022
3.6 Manufacturer by Geography: Head Office and Brigatinib Tablet Production Site
3.7 New Entrant and Capacity Expansion Plans
3.8 Mergers & Acquisitions
4 Market Analysis by Region
4.1 Global Brigatinib Tablet Market Size by Region
4.1.1 Global Brigatinib Tablet Sales in Volume by Region (2017-2028)
4.1.2 Global Brigatinib Tablet Revenue by Region (2017-2028)
4.2 North America Brigatinib Tablet Revenue (2017-2028)
4.3 Europe Brigatinib Tablet Revenue (2017-2028)
4.4 Asia-Pacific Brigatinib Tablet Revenue (2017-2028)
4.5 South America Brigatinib Tablet Revenue (2017-2028)
4.6 Middle East and Africa Brigatinib Tablet Revenue (2017-2028)
5 Market Segment by Type
5.1 Global Brigatinib Tablet Sales in Volume by Type (2017-2028)
5.2 Global Brigatinib Tablet Revenue by Type (2017-2028)
5.3 Global Brigatinib Tablet Price by Type (2017-2028)
6 Market Segment by Application
6.1 Global Brigatinib Tablet Sales in Volume by Application (2017-2028)
6.2 Global Brigatinib Tablet Revenue by Application (2017-2028)
6.3 Global Brigatinib Tablet Price by Application (2017-2028)
7 North America by Country, by Type, and by Application
7.1 North America Brigatinib Tablet Sales by Type (2017-2028)
7.2 North America Brigatinib Tablet Sales by Application (2017-2028)
7.3 North America Brigatinib Tablet Market Size by Country
7.3.1 North America Brigatinib Tablet Sales in Volume by Country (2017-2028)
7.3.2 North America Brigatinib Tablet Revenue by Country (2017-2028)
7.3.3 United States Market Size and Forecast (2017-2028)
7.3.4 Canada Market Size and Forecast (2017-2028)
7.3.5 Mexico Market Size and Forecast (2017-2028)
8 Europe by Country, by Type, and by Application
8.1 Europe Brigatinib Tablet Sales by Type (2017-2028)
8.2 Europe Brigatinib Tablet Sales by Application (2017-2028)
8.3 Europe Brigatinib Tablet Market Size by Country
8.3.1 Europe Brigatinib Tablet Sales in Volume by Country (2017-2028)
8.3.2 Europe Brigatinib Tablet Revenue by Country (2017-2028)
8.3.3 Germany Market Size and Forecast (2017-2028)
8.3.4 France Market Size and Forecast (2017-2028)
8.3.5 United Kingdom Market Size and Forecast (2017-2028)
8.3.6 Russia Market Size and Forecast (2017-2028)
8.3.7 Italy Market Size and Forecast (2017-2028)
9 Asia-Pacific by Region, by Type, and by Application
9.1 Asia-Pacific Brigatinib Tablet Sales by Type (2017-2028)
9.2 Asia-Pacific Brigatinib Tablet Sales by Application (2017-2028)
9.3 Asia-Pacific Brigatinib Tablet Market Size by Region
9.3.1 Asia-Pacific Brigatinib Tablet Sales in Volume by Region (2017-2028)
9.3.2 Asia-Pacific Brigatinib Tablet Revenue by Region (2017-2028)
9.3.3 China Market Size and Forecast (2017-2028)
9.3.4 Japan Market Size and Forecast (2017-2028)
9.3.5 Korea Market Size and Forecast (2017-2028)
9.3.6 India Market Size and Forecast (2017-2028)
9.3.7 Southeast Asia Market Size and Forecast (2017-2028)
9.3.8 Australia Market Size and Forecast (2017-2028)
10 South America by Region, by Type, and by Application
10.1 South America Brigatinib Tablet Sales by Type (2017-2028)
10.2 South America Brigatinib Tablet Sales by Application (2017-2028)
10.3 South America Brigatinib Tablet Market Size by Country
10.3.1 South America Brigatinib Tablet Sales in Volume by Country (2017-2028)
10.3.2 South America Brigatinib Tablet Revenue by Country (2017-2028)
10.3.3 Brazil Market Size and Forecast (2017-2028)
10.3.4 Argentina Market Size and Forecast (2017-2028)
11 Middle East & Africa by Country, by Type, and by Application
11.1 Middle East & Africa Brigatinib Tablet Sales by Type (2017-2028)
11.2 Middle East & Africa Brigatinib Tablet Sales by Application (2017-2028)
11.3 Middle East & Africa Brigatinib Tablet Market Size by Country
11.3.1 Middle East & Africa Brigatinib Tablet Sales in Volume by Country (2017-2028)
11.3.2 Middle East & Africa Brigatinib Tablet Revenue by Country (2017-2028)
11.3.3 Turkey Market Size and Forecast (2017-2028)
11.3.4 Egypt Market Size and Forecast (2017-2028)
11.3.5 Saudi Arabia Market Size and Forecast (2017-2028)
11.3.6 South Africa Market Size and Forecast (2017-2028)
12 Raw Material and Industry Chain
12.1 Raw Material of Brigatinib Tablet and Key Manufacturers
12.2 Manufacturing Costs Percentage of Brigatinib Tablet
12.3 Brigatinib Tablet Production Process
12.4 Brigatinib Tablet Industrial Chain
13 Sales Channel, Distributors, Traders and Dealers
13.1 Sales Channel
13.1.1 Direct Marketing
13.1.2 Indirect Marketing
13.2 Brigatinib Tablet Typical Distributors
13.3 Brigatinib Tablet Typical Customers
14 Research Findings and Conclusion
15 Appendix
15.1 Methodology
15.2 Research Process and Data Source
15.3 Disclaimer
❖ 免責事項 ❖
http://www.globalresearch.jp/disclaimer